hyperphosphatasia with intellectual disability syndrome 3

Rare Disease

MONDO:0013628

Also known as:

PGAP2 hyperphosphatasia-intellectual disability syndromehyperphosphatasia with intellectual disability syndrome 3hyperphosphatasia with intellectual disability syndrome type 3

Any hyperphosphatasia-intellectual disability syndrome in which the cause of the disease is a mutation in the PGAP2 gene.

Genes

Clinical Trials

–

Newborn Screening

–

Patient Groups

–

Patient-Friendly Information

Comprehensive, easy-to-understand information about this condition

How we create this content →

Report Generation Failed

We couldn't automatically generate the report. This may be due to temporary service issues.

Companies Active in hyperphosphatasia with intellectual disability syndrome 3

0 approved

Organizations with approved therapies for this disease

No approved therapies yet

Research is ongoing — 2 companies have orphan drug designations for this disease

Fresenius Medical Care North America

Other

Designated

Pharmedic Company

Other

Designated

View all companies active in hyperphosphatasia with intellectual disability syndrome 3

Need this data in your product?

Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.

Explore API Start Free

← Back to All Diseases